Skip to main content
Clinical Trials/NCT02685358
NCT02685358CompletedNot Applicable

An RCT of a Primary Care-Based PTSD Intervention: Clinician-Supported PTSD Coach

VA Office of Research and Development4 sites in 1 country234 target enrollmentStarted: March 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
234
Locations
4
Primary Endpoint
Hospital Administrative Data Showing 2 Mental Health Visits Completed

Study Overview

Brief Summary

Posttraumatic Stress Disorder (PTSD) is an often severe and frequently disabling condition. It is associated with compromised health, early mortality, and substantial economic costs. PTSD is common in VA primary care patients; however, brief, effective treatments for PTSD are not available in the primary care setting. Instead, patients with PTSD are referred to mental health settings, yet many patients do not accept these referrals or do not adequately engage in such services. Thus, this project seeks to improve health care for Veterans by testing the effectiveness of a primary care-based treatment called clinician-supported PTSD Coach. In this treatment a primary care mental health clinician guides patients in using the PTSD Coach mobile app to learn about PTSD symptoms, treatment options, and strategies to cope with common PTSD-related concerns. If this treatment is found to be effective at reducing PTSD symptoms and increasing use of mental health care, it will provide a tremendous benefit to Veterans with PTSD seen in VA primary care.

Detailed Description

Posttraumatic Stress Disorder (PTSD) is an often severe and frequently disabling condition. It is associated with compromised health, early mortality, and substantial economic costs. PTSD is common in VA primary care patients; however, brief, effective treatments for PTSD are not available in the primary care setting. Instead, patients with PTSD are referred to mental health settings, yet many patients do not accept these referrals or do not adequately engage in such services. Thus, this project represents a unique opportunity to improve health care for Veterans by examining the effectiveness of a primary care-based treatment called Clinician-Supported PTSD Coach. In this treatment a primary care mental health clinician guides patients in using the PTSD Coach mobile app to learn about PTSD symptoms, treatment options, and strategies to cope with common PTSD-related concerns. This randomized clinical trial will enroll and treat 260 VA primary care patients (female and male) who have PTSD and are not currently being treated for it. Commonly used, well-established clinical interviews and self-report measures will be used to assess important clinical outcomes. If this direct treatment is found to be effective at reducing PTSD symptoms and increasing use of mental health care, it will provide a tremendous benefit to Veterans with PTSD seen in VA primary care.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Outcomes Assessor)

Masking Description

The CAPS-5 will be administered via phone by a central assessor, blind to condition, at baseline and post-treatment and will be the primary measure of change in PTSD symptom severity.

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Veterans enrolled in primary care within the VA Syracuse and Palo Alto healthcare systems reporting 33 on the PTSD Checklist-5 (PCL-5) and a traumatic event on the Criterion A screener

Exclusion Criteria

  • Patients will be excluded if they demonstrate symptoms that would not allow them to actively engage in the CS PTSD Coach, i.e.,
  • gross cognitive impairment
  • Current symptoms of mania or psychosis or who have more pressing concerns that need to be addressed first, i.e.,
  • suicide attempt in the last two months or current intent to commit suicide
  • Patients with recent suicide attempts or intent are eligible to be enrolled follow the receipt of suicide prevention services
  • The investigators will also exclude patients that are already receiving psychotherapy or MH counseling for PTSD outside of PC
  • Started or changed the dose of a psychotropic medication for PTSD in the last two months that was prescribed outside of VA PC
  • Voice a preference to be directly referred to MH specialty care

Outcomes

Primary Outcomes

Hospital Administrative Data Showing 2 Mental Health Visits Completed

Time Frame: 16 and 24 weeks

Hospital administrative data will be examined to determine if the participant completed 2 visits to any specialty mental health clinic during the follow-up period.

Clinician Administered PTSD Scale for DSM-5 (CAPS-5)

Time Frame: Baseline

The CAPS-5 is a 30-item clinical interview that assesses the 20 DSM-5 PTSD symptoms. Scores on the CAPS-5 can range from 0 to 80, with higher scores reflecting worse PTSD symptom severity. In this study, clinician-rated PTSD symptom severity were based on blind assessor ratings.

Secondary Outcomes

  • Patient Health Questionnaire (PHQ-9)(Baseline, 8 week, 16 week, 24 week)
  • WHOQOL-BREF Social Relationships Subscale(Baseline, 8 week, 16 week, 24 week)
  • PTSD Checklist-5 (PCL-5)(Baseline, 8 week, 16 week, 24 week)
  • Client Satisfaction Questionnaire (CSQ)(8 week)
  • WHOQOL-BREF Psychological Health Subscale(Baseline, 8 week, 16 week, 24 week)

Investigators

Sponsor Class
Fed
Responsible Party
Sponsor

Study Sites (4)

Loading locations...

Similar Trials

An RCT of a Primary Care-Based PTSD... | Clinical Trial